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A B S T R A C T
Post-traumatic stress disorder (PTSD) is a debilitating mental disorder precipitated by trauma exposure.
However, only some persons exposed to trauma develop PTSD. There are sex differences in risk; twice as many
women as men develop a lifetime diagnosis of PTSD. Methylomic profiles derived from peripheral blood are
well-suited for investigating PTSD because DNA methylation (DNAm) encodes individual response to trauma and
may play a key role in the immune dysregulation characteristic of PTSD pathophysiology. In the current study,
we leveraged recent methodological advances to investigate sex-specific differences in DNAm-based leukocyte
composition that are associated with lifetime PTSD. We estimated leukocyte composition on a combined me-
thylation array dataset (483 participants, ∼450 k CpG sites) consisting of two civilian cohorts, the Detroit
Neighborhood Health Study and Grady Trauma Project. Sex-stratified Mann-Whitney U test and two-way
ANCOVA revealed that lifetime PTSD was associated with significantly higher monocyte proportions in males,
but not in females (Holm-adjusted p-val < 0.05). No difference in monocyte proportions was observed between
current and remitted PTSD cases in males, suggesting that this sex-specific difference may reflect a long-standing
trait of lifetime history of PTSD, rather than current state of PTSD. Associations with lifetime PTSD or PTSD
status were not observed in any other leukocyte subtype and our finding in monocytes was confirmed using cell
estimates based on a different deconvolution algorithm, suggesting that our sex-specific findings are robust
across cell estimation approaches. Overall, our main finding of elevated monocyte proportions in males, but not
in females with lifetime history of PTSD provides evidence for a sex-specific difference in peripheral blood
leukocyte composition that is detectable in methylomic profiles and that may reflect long-standing changes
associated with PTSD diagnosis.
1. Introduction
Post-traumatic stress disorder (PTSD) is a debilitating mental dis-
order that is precipitated by a traumatic experience involving direct or
indirect exposure to actual or threatened death, serious injury, or sexual
violence (American Psychiatric Association, 2013). PTSD presents with
intrusive and persistent re-experiencing of the traumatic event, avoid-
ance of distressing, trauma-associated stimuli, negative alterations in
cognition and mood, and alterations in arousal/reactivity that persist
for longer than a month (American Psychiatric Association, 1994;
2013). While most individuals are exposed to a potentially traumatic
event at some point in their lives, only some develop PTSD (Breslau,
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2015); moreover, given the well-known sex difference in PTSD pre-
valence and in immune response (Klein and Flanagan, 2016; Osborne
et al., 2018), sex-stratified investigation relating to these dual factors is
warranted to identify potential differences in variability by sex that
may be missed in analyses combining both sexes.
Peripheral blood-based methylomic profiles are comprised of two
dynamic components: 1) profiles reflecting proportions of immune cell
subtypes (i.e., leukocyte composition) and 2) alterations in DNAm le-
vels at CpG sites genome-wide (i.e., differential methylation).
Epigenome-wide association studies (EWAS) often seek to identify dy-
namic differential methylation marks and treat cellular heterogeneity as
a major confound that must be addressed to improve signal detection.
However, differences in leukocyte subtypes provide key insights into
immunological changes and warrant examination themselves. Recent
developments in deconvolution algorithms and cell-type discriminating
reference databases have improved estimates (Titus et al., 2017;
Teschendorff et al., 2017; Koestler, 2016; Salas, 2018) and enabled
utility of DNAm-based leukocyte subtype estimates as proxies for white
blood cell differential-based metrics (Wiencke, 2017; Koestler, 2017).
Leveraging these recently developed methods, here we use leukocyte-
derived methylomic profiles combined from two civilian cohorts to
investigate our hypothesis that PTSD is associated with sex-specific
differences in leukocyte composition, detectable by DNAm-based esti-
mates. To our knowledge, this study is the first to investigate leukocyte
composition profiles in PTSD using these new DNAm-based approaches
for immune profiling.
2. Materials and methods
2.1. Study participants
Samples from trauma-exposed, adult participants with available
Illumina HumanMethylation450 (450 K) BeadChip array data were se-
lected from two predominantly African-American, community-based
cohorts examining biological and environmental correlates of PTSD,
namely the Detroit Neighborhood Health Study (DNHS; n=192) and
Grady Trauma Project (GTP; n= 422). The DNHS, based in Detroit, MI,
was approved by the institutional review boards of the University of
Michigan and University of North Carolina at Chapel Hill. The GTP,
based in Atlanta, GA, was approved by the institutional review boards
of Emory University School of Medicine and Grady Memorial Hospital.
All participants provided written informed consent prior to data col-
lection. Details regarding the DNHS (Uddin, 2010; Goldmann, 2011;
Meyers, 2015) and GTP (Gillespie, 2009; Binder, 2008; Zannas, 2015)
were published previously. While neither study excluded participants
based on illness, women known to be pregnant (in the GTP) were ex-
cluded from estimation and analyses, due to well-known/known sig-
nificant differences in leukocyte composition during pregnancy (Luppi,
2003). Collected demographic data included self-reported gender, race,
age, and current smoking, which was defined as any cigarette smoking
in the past 30 days.
2.2. Assessment of PTSD
Study participants were assessed for PTSD, as defined by the
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV) (American Psychiatric Association, 2013). In the DNHS, study
participants were assessed for PTSD using the well-validated self-report
PTSD Checklist, Civilian Version (PCL-C) (Blanchard et al., 1996;
Grubaugh et al., 2007; Wilkins et al., 2011; Ruggiero et al., 2003) and
additional questions about duration, timing, and impairment due to
symptoms, via structured telephone interviews (Breslau, 1998; Uddin,
2010; Koenen, 2011). Participants who met all six DSM-IV criteria in
reference to their worst traumatic event or to a randomly selected
traumatic event (if the participant experienced more than one trauma),
were considered affected by lifetime PTSD. Those that met criteria
2009; Kessler et al., 1995; Kilpatrick, 2013; Liu, 2017; Benjet, 2016; 
Kessler, 2005; Kessler and Wang, 2008), suggesting that the disorder 
reflects a distinct inability to reinstate homeostasis after psychological 
trauma in vulnerable individuals (Yehuda et al., 2011).
Epidemiological studies have identified sex to be a significant vul-
nerability factor for developing PTSD, with women twice as likely to 
have lifetime PTSD than men, even when risk of exposure and types of 
trauma are taken into consideration (Kessler et al., 1995; Kilpatrick, 
2013; Kessler and Wang, 2008; Breslau, 1998; Breslau et al., 1997; 
Tolin and Foa, 2006). This sex bias in disease prevalence is also ob-
served in other stress-related mood and anxiety disorders (Kessler, 
1994), including depression (Kessler et al., 1993). Preclinical and 
clinical investigations have identified sexual dimorphism in stress re-
sponse systems that may be involved in the increased prevalence of 
stress-related psychopathologies in women (Hodes, 2013; Bangasser 
and Valentino, 2014). Furthermore, in addition to sexual dimorphism in 
the neurobiological underpinnings of stress/trauma response, recent 
animal studies suggest that behavioral response to traumatic stress is 
fundamentally different b etween m ales a nd f emales a nd s hould be 
considered in interpretation of results (Pooley, 2018). In humans, re-
sponse to stress/trauma exposure involves both biological and social 
contributors corresponding to sex and gender-related variables. While 
the effects of sex and gender are difficult to disentangle, investigations 
stratified by biological sex, understood to interact with gender-related 
variables, are warranted to improve our currently limited under-
standing of the sex-specific biological processes dysregulated in PTSD 
pathophysiology.
Mounting evidence suggests a key role for stress-induced in-
flammation a nd i mmune a lteration i n t he d evelopment a nd main-
tenance of PTSD and other stress-related psychiatric disorders. 
Although findings from human literature have been mixed, PTSD has 
generally been associated with increased pro-inflammatory t one, ba-
sally and in response to immune challenge, via both cytokine signaling 
and changes in immune cell distribution/function (Passos, 2015; 
Michopoulos et al., 2017; Wang and Young, 2016; Kawamura et al., 
2001; Altemus et al., 2003; G lover et al., 2005; G ill et al., 2009; 
G otovac, 2010; Lindqvist, 2014; Aiello, 2016; Lindqvist, 2017; 
Sondergaard et al., 2004; Sommershof, 2009; Hoge, 2009; Michopoulos 
et al., 2015; Bersani, 2016; Wang et al., 2016). Investigations in animal 
models, primarily in male rodent studies, have provided mechanistic 
insights into how peripheral immune cell response/signaling and dis-
tribution is linked with microglial activation and neuroinflammatory 
dynamics to trigger stress-induced anxiety behavior and memory im-
pairment (Wohleb, 2011; Wohleb et al., 2013; Wohleb, 2014; McKim, 
2016a,b; Wohleb and Delpech, 2017; Yin, 2019).
Epigenetic mechanisms have emerged as important regulators of 
PTSD-associated immune dysregulation and inflammation (Bam, 2016; 
Zhou, 2014; Uddin, 2010; Rusiecki, 2013; Bam, 2016; Smith, 2011), 
and are particularly significant f or t he s tudy o f P TSD b ecause they 
capture the interactions among pre-disposing genetic/environmental 
risk factors and the precipitating trauma exposure. Individual response 
to trauma exposure can be encoded as short-lived or persistent epige-
netic changes that reflect a nd may c ontribute t o p osttraumatic phy-
siological changes, some of which remain after remission of PTSD 
symptoms. DNA methylation (DNAm) has been the most widely studied 
epigenetic mechanism and evidence from both animal and human 
models point to its key role in stress regulation (Yehuda et al., 2011; 
Weaver, 2004; McGowan, 2009; Stankiewicz et al., 2013), fear memory 
(Miller et al., 2008; Maddox et al., 2013; Zovkic and Sweatt, 2013; 
Malan-Muller et al., 2014; Kwapis and Wood, 2014), and immune 
function (Uddin, 2010; Rusiecki, 2013; Bam, 2016; Smith, 2011; 
Alvarez-Errico et al., 2015; Sun, 2016; Chen, et al., 2016; Wolf, 2018), 
in both brain and blood. Exploring PTSD-associated DNAm profiles in 
blood may inform our understanding of mechanisms underlying im-
mune dysregulation, particularly those that coordinate peripheral im-
mune-neuroimmune crosstalk (Irwin and Cole, 2011; Pfau and Russo,
times interquartile range (IQR) from the lower quartile or> 3 times
IQR from the upper quartile); 4) greater than three standard deviations
of the mean bisulfite conversion control probe signal intensity (Salas,
2018). Additionally, samples were checked for gender discordance
based on median total intensity of X and Y-chromosome mapped probes
(as implemented in minfi) (Aryee, 2014) and removed if predicted sex
differed from self-reported gender. Five samples were removed among
DNHS samples for gender discordance, and six samples were removed
among GTP samples (two for data quality and four for gender dis-
cordance). After within-array background correction and dye-bias
equalization using out-of-band control probes (ssNoob, minfi) (Fortin
et al., 2017; Triche et al., 2013), probes with detection p-value >
0.001 in> 10% of samples (Barfield et al., 2012) and cross-reactive
probes (Chen, 2013) (i.e., cross-hybridized between autosomes and sex
chromosomes) were removed. Beta-mixture quantile (BMIQ) normal-
ization (ChAMP) (Morris, 2014; Tian, 2017) was used to correct for type
II probe bias (Teschendorff, 2013).
To control for technical artifacts (e.g., sample processing and ima-
ging batch effects), principal components (PCs) based on non-negative
control probe signal intensity (Xu et al., 2016) were removed from
BMIQ-normalized M-values (i.e., logit-transformed beta-values) sepa-
rately for each study. PC correlation heatmaps were used to check for
successful removal/reduction of batch effects, especially chip and row
effects, while maintaining signal from biological variables. The DNHS
and GTP datasets were then combined and an empirical Bayes method
(i.e., ComBat (Johnson et al., 2007) in the sva package (Leek et al.,
2012) was used on the combined M-values to account for study effects
while controlling for sex and age. Data quality assessment, QC probe
filtering, and first step of batch removal were study-specific, while pre-
processing steps (ssNoob+BMIQ) implemented within-array ap-
proaches unaffected by study. Only probes that passed QC in both
studies (n=455,072 probes) were included in the combined dataset.
2.5. Leukocyte composition estimation
Leukocyte composition was estimated on ComBat-adjusted beta-
values using the EpiDISH (Teschendorff et al., 2017) reference database,
which is informed by cell-type specific DNase hypersensitive sites (DHS;
based on the NIH Epigenomics Roadmap database (Roadmap
Epigenomics, 2015)) and is optimized for discriminating granulocytes,
Table 1
Key demographic characteristics, by Sex.
Female(n=330) Male(n=153) Total(n=483)
Study
DNHS 111 (33.6%) 64 (41.8%) 175 (36.2%)
GTP 219 (66.4%) 89 (58.2%) 308 (63.8%)
Race
AA 291 (88.2%) 140 (91.5%) 431 (89.2%)
CA 33 (10.0%) 11 (7.2%) 44 (9.1%)
Other 6 (1.8%) 2 (1.3%) 8 (1.7%)
Median Age
49.0 (38.0–55.0) 48.0 (36.0–56.0) 48.0 (37.5–55.0)
Current Smoking
no 210 (63.6%) 72 (47.1%) 282 (58.4%)
yes 109 (33.0%) 78 (51.0%) 187 (38.7%)
Missing 11 (3.3%) 3 (2.0%) 14 (2.9%)
Lifetime PTSD
no 135 (40.9%) 71 (46.4%) 206 (42.7%)
yes 195 (59.1%) 82 (53.6%) 277 (57.3%)
This table describes the subset of participants included in primary analyses
investigating sex-specific associations between DNAm-based cell estimates and
lifetime PTSD, by sex. For the 2-way ANCOVA, 14 participants were excluded
due to missing current smoking data.
DNHS: Detroit Neighborhood Health Study; GTP: Grady Trauma Project
based on symptoms reported within the past month were considered 
affected by current PTSD. Analysis of data from the clinical interviews 
showed that the PTSD instrument used during structured telephone 
interviews had excellent internal consistency and high concordance 
(Uddin, 2010; Uddin, 2011). The PCL-C yielded a Cronbach coefficient 
alpha (α) of 0.93. Using cluster scoring based on DSM-IV criteria (i.e. to 
be a case, the participant’s symptoms had to meet all six criteria), the 
instrument had a specificity (SP) of 0.97, sensitivity (SE) of 0.24, po-
sitive predictive value (PPV) of 0.80, negative predictive value (NPV) 
0.72, and an area under the ROC curve (AUC) of 0.76, as previously 
reported (Uddin, 2010; Uddin, 2011). In the GTP (Jovanovic, 2010), 
study participants were assessed for lifetime and current PTSD using the 
Clinician-Administered Post-traumatic Stress Disorder Scale (CAPS, 
DSM-IV), a structured interview administered by a clinician that has 
previously been shown to have excellent reliability (i.e., consistent 
scores across items, raters, testing occasions) and excellent convergent 
and discriminant validity in large scale psychometric studies (Blake, 
1995; Weathers et al., 2001). For lifetime analyses, participants 
meeting criteria for PTSD at any point (including current and past 
PTSD) were considered cases and compared to trauma-exposed controls 
who lacked a history of PTSD at any point in their lifetime. For com-
parisons of current PTSD with remitted PTSD and trauma exposed 
controls, participants with lifetime PTSD were further separated into 
two groups: those with current PTSD and those with lifetime (but not 
current) PTSD.
2.3. Sample processing
In the DNHS, samples were obtained via an in-home blood draw 
performed by a clinician, processed in the lab within two hours, and 
stored at −20 °C until testing. Detailed methods regarding biospecimen 
processing in the DNHS are available in a separate publication (Weckle, 
2015). In the GTP, DNA was extracted from whole blood, aliquoted, and 
frozen at −80 °C within two hours of collection. Genomic DNA was 
extracted from peripheral blood using the DNA Mini Kit (Qiagen, Ger-
mantown, MD) in the DNHS and the G entra Puregene Kit (Qiagen, 
Germantown, MD) in the GTP. Both studies bisulfite-converted the DNA 
samples using the Zymo EZ-96 DNA methylation kit (Zymo Research, 
Irvine, CA) and used 500 ng of DNA per sample for whole-genome 
amplification, fragmentation, and hybridization to the Illumina Human 
Methylation 450 K BeadChip array (Illumina, San Diego, CA), according 
to the manufacturers’ recommended protocols. Sample processing 
procedures have been published previously for both the DNHS and GTP 
(Wolf, 2018; Zannas, 2015; Ratanatharathorn, 2017; Uddin, 2018; 
Mehta, 2013).
2.4. Quality control and pre-processing of 450 K data
The raw .idat files w ere i mported i nto R  ( version 3 .5.1) (R 
Foundation for Statistical Computing, Vienna, Austria, 2018), using the 
minfi package (Aryee, 2014), available on Bioconductor (version 3.7)
(Huber, 2015; Gentleman, 2004), for all subsequent data processing 
and analyses. After quality control (QC) (Aryee, 2014; Barfield et al., 
2012; Xu et al., 2016), data pre-processing (Liu and Siegmund, 2016; 
Fortin et al., 2017; Chen, 2013; Teschendorff, 2013; Morris, 2014; Tian, 
2017) was conducted on all QC’ed samples (DNHS: n = 187; GTP: 
n = 416). This included duplicates (n = 12) in the DNHS and partici-
pants with known pregnancy (n = 26) or missing PTSD phenotype data 
(n = 82) in the GTP. Analyses were conducted on unique participants 
that passed QC, as described below, and had PTSD data available 
(Table 1).
For data quality assessment, samples were checked for 1) low total 
signal (mean signal intensity less than half of the overall median, after 
setting probes with detection p-value > 0.001 or < 2,000 arbitrary 
units to missing); 2) > 1% of failed probes (detection p-value > 
0.001); 3) outlying beta value distribution (i.e., smaller than three
CD14+ monocytes, CD8+ T cells, CD4+ T cells, CD19+ B cells, and
CD56+ natural killer cells. Robust partial correlation (RPC; robust
multivariate linear regression, non-constrained projection) was used as
the primary deconvolution algorithm and EpiDISH’s implementation of
linear, constrained projection (CP), originally introduced by Houseman
(2012), was used to calculate a second set of estimates for comparison.
2.6. Ancestry estimation
DNAm-based ancestry PCs were derived on cleaned beta-values
after regressing out sex and age from batch-adjusted M-values. Ancestry
PCs were calculated on a subset of 2,317 ancestry informative CpG
probes included in two published ancestry informative CpG lists that
accounted for confounders (Rahmani, 2017) and that included probes
within 10 base pairs (bp) of single nucleotide polymorphisms (SNPs)
(Barfield, 2014). The first 2 PCs based on this subset of probes were
used as ancestry PCs (ancPCs) after checking for strong association with
self-reported race and effective separation of self-reported races.
2.7. Statistical analysis
The Shapiro-Wilk test was used to assess normality and Levene’s test
was used to compare equality of variance among groups. Since cell
estimates had dissimilar, non-normal distributions, non-parametric
tests were used for all initial group comparisons of leukocyte subtypes.
The two-sample Kolmogorov-Smirnov (KS) test was used to compare
distribution of cell estimates when variances were unequal between
groups and Mann-Whitney U test was used to compare mean ranks of
cell estimates otherwise. Spearman’s rank correlation was used to assess
agreement between estimates based on RPC and CP deconvolution
approaches. A threshold of 0.05 was used for p-values and p-values
were adjusted for multiple comparisons using Holm’s method (Holm,
1979), unless otherwise specified.
To test our main hypothesis—that PTSD is associated with sex-
specific differences in leukocyte composition—initial sex-stratified
analyses were conducted on all leukocyte subtypes using the non-
parametric Mann-Whitney U test. For leukocyte subtypes determined to
be significantly associated with lifetime PTSD in either sex based on
initial Mann-Whitney U tests, a two-way analysis of covariance
(ANCOVA; Type III) controlling for age, ancestry (based on DNAm
ancestry PCs), and current smoking, was performed with post-hoc
comparison of estimated marginal means to examine the effects of sex
and lifetime PTSD on transformed cell estimates. Transformation for
cell estimate was conducted to meet modeling assumptions for
ANCOVA and was informed by Tukey’s Ladder of Powers. Power
parameter (λ) was computed to maximize normality based on the
Shapiro-Wilks W statistic. Sex-stratified Kruskal-Wallis and post-hoc
Dunn tests were conducted as additional follow-up to investigate pos-
sible differences in cell proportions by PTSD status (i.e., trauma-ex-
posed controls, remitted PTSD, and current PTSD).
3. Results
3.1. Demographic characteristics of sampled study participants from the
DNHS and GTP
The demographic characteristics of study participants included in
primary analyses investigating sex-specific associations between
DNAm-based cell estimates and lifetime PTSD are presented in Table 1.
Of the 483 participants from the combined DNHS and GTP sample,
57.3% had a lifetime diagnosis of PTSD, 68.3% were female, and 38.7%
were current smokers. The study population was predominantly
African-American (89.2%), based on self-reported race, and the median
age was 48 years (IQR: 17.5; 37.5–55 years).
3.2. Comparison of leukocyte subtype estimates by deconvolution approach
Good overall agreement was observed between RPC and CP esti-
mates, as measured by Spearman’s correlation (i.e., RPC-CP correla-
tion), but CD8+ T cells (CD8T) showed much poorer agreement,
ρs(4 8 1)= 0.83, relative to the other leukocyte subtypes,
ρs(4 8 1) > 0.94 (Fig. 1). Since the main objective of this study was to
Fig. 1. Correlation (Spearman’s rho) between cell estimates derived using robust partial correlation (RPC) and constrained projection (CP) deconvolution algorithms
is high in all leukocyte subtypes, with CD8+ T cells (CD8T) showing the worst agreement at R=0.8 in females and R=0.87 in males. CD8T cells also showed the
largest discrepancy in sex-specific correlation of estimates. RPC-CP correlation was > 0.9 and difference in RPC-CP correlation between sexes was between 0.01 and
0.03 for all other leukocyte subtypes.
monocyte proportions than trauma-exposed controls, U=2100,
Z=−2.9, p=0.004, adj. p=0.026, r=0.23. In contrast, no differ-
ence in monocyte estimates was found between groups in females,
U=13000, Z=−0.58, p=0.6, adj. p=1, r=0.03. Lifetime PTSD-
associated differences were not observed in any other leukocyte sub-
types in either sex.
A two-way ANCOVA was conducted to investigate whether sex
moderated the effects of lifetime PTSD on transformed monocyte esti-
mates, while accounting for age, ancestry, and current smoking
(Table 2). Monocyte estimates were square root transformed for the
ANCOVA to meet model assumptions (i.e., normality) and were in-
formed by Tukey’s Ladder of Powers (RPC: λ=0.43; CP: λ= 0.5). A
significant interaction was found between sex and lifetime PTSD, F(1,
461)= 4.89, p=0.027, ηp2= 0.011. Post-hoc comparison of estimated
marginal means (EMMs) for lifetime PTSD by sex (Fig. 5; Table 3)
showed a significant mean difference between lifetime PTSD cases and
controls in males, ΔEMM=0.26, SE=0.08, t(4 6 1)= 3.32, p=0.001,
where mean monocyte estimates were higher in lifetime PTSD cases
than controls. No significant mean difference was observed between
PTSD cases and controls in females, ΔEMM=0.05, SE=0.05, t
(4 6 1)= 0.89, p=0.37, confirming findings from initial sex-stratified
analyses. Together, our results suggest that male PTSD cases have sig-
nificantly elevated monocyte proportions compared to trauma-exposed
controls and that this lifetime PTSD-associated difference is not ob-
served in females.
3.5. Association between monocyte proportions and lifetime PTSD in males
is independent of current PTSD status
To investigate whether participants with current PTSD exhibited a
different monocyte profile from those with remitted PTSD, a sex-stra-
tified Kruskal-Wallis test was conducted for PTSD status (i.e., trauma-
exposed controls, remitted PTSD, and current PTSD; Fig. 6). A sig-
nificant difference in monocyte estimates was observed in males, H
(2)= 8.2, p=0.017, but not in females, H(2)= 1.1, p=0.59, con-
firming findings from analyses for lifetime PTSD. The post-hoc Dunn
test revealed significant differences between PTSD case groups and
trauma-exposed controls (current PTSD vs. controls: Z=2.31,
Fig. 2. Distribution of leukocyte subtypes based on robust partial correlation (RPC) estimates, by sex. Sex differences in CD8+ T and CD56+ NK cell distributions
were found to be prominent.
investigate sex-specific differences in  leukocyte composition, compar-
ison of RPC and CP estimates was stratified by sex. Sex-stratified RPC-
CP correlation revealed that the largest difference in RPC-CP correla-
tion between sexes was also found in CD8T cells, |Δρs| = 0.07, such that 
females showed poorer correlation, ρs(3 2 8) = 0.80, than males, 
ρs(1 5 1) = 0.87. For the other leukocyte subtypes, the difference in 
RPC-CP correlation between sexes (|Δρs|), ranged from 0.01 to 0.03, 
with CD56+ natural killer (NK) cells having the second largest differ-
ence in correlation between sexes (female: ρs(3 2 8) = 0.93; male: 
ρs(1 5 1) = 0.96). In all leukocyte subtypes, except CD19+ B cells, fe-
males had lower correlation coefficients than males. Detailed results for 
RPC-based cell estimates are reported below and corresponding results 
based on CP-based estimates are reported in supplementary materials, 
due to strong agreement between findings from both sets of estimates.
3.3. Comparison of leukocyte subtype estimates by sex and lifetime PTSD
Cell estimates were compared by sex, lifetime PTSD, and study in 
each leukocyte subtype to establish overall differences. Significant 
overall sex differences were observed in the distributions o f NK (KS: 
D = 0.19, adj. p = 0.007) and CD8T cell proportions (KS: D = 0.16; adj. 
p = 0.04) in RPC estimates. Males showed greater variability than fe-
males for both NK and CD8T cells (male vs. female – IQRNK: 6.2% vs. 
4.15%; IQRCD8T: 9.5% vs. 6.2%), as well as higher median NK (5.5% vs. 
4.4%) and lower median CD8T (9.0% vs. 9.7%) cell proportions 
(Fig. 2). No significant overall differences (i.e., in both sexes combined) 
were observed between lifetime PTSD cases and trauma-exposed con-
trols in any leukocyte subtype (Mann-Whitney). Additional analyses 
comparing leukocyte subtype proportions between participating co-
horts and assessing age effects in each cell type are reported in sup-
plementary materials.
3.4. Elevated monocyte proportions were associated with lifetime PTSD in 
males, but not females
Sex-stratified Mann-Whitney U  t ests r evealed a  s ignificant differ-
ence in monocyte proportions between PTSD cases and controls in 
males (Figs. 3 and 4). Males with lifetime PTSD had higher median
p=0.021, adj. p=0.042, r=0.23; remitted PTSD vs. controls:
Z=2.40, p=0.016, adj. p=0.049, r=0.22), but no significant dif-
ference between current and remitted PTSD groups, Z=0.18, p=0.86,
adj. p=0.86, r=0.02. These findings suggest that the association
between monocyte proportions and lifetime PTSD in males is in-
dependent of current PTSD state and may reflect long-standing changes
associated with lifetime history of PTSD diagnosis.
Comparative analyses based on CP monocyte estimates showed si-
milar results to RPC-based results (see Supplementary Materials);
however, CP-based results consistently presented smaller effect sizes
than RPC-based results across all analyses and follow-up comparisons
between PTSD case groups and trauma-exposed controls did not reach
significance after p-value adjustment in post-hoc Dunn test using CP
monocyte estimates in males.
Fig. 3. Violin plots of RPC estimates for lifetime PTSD cases and controls, stratified by sex. Only monocyte proportions in males showed a statistically significant
difference between lifetime PTSD cases and controls, based on Mann-Whitney U test (p-value=0.004; Holm-adjusted p-value=0.026). For figure labels on x-axis:
B=CD19+ B cells; NK=CD56+ NK cells; CD4T=CD4+ T cells; CD8T=CD8+ T cells; Gran=Granulocytes; Mono=CD14+ monocytes.
Fig. 4. Density plots for RPC monocyte estimates in lifetime PTSD cases and controls, stratified by sex, show distinctly higher monocyte levels in males with lifetime
PTSD compared to trauma-exposed controls. This difference in monocyte levels between lifetime PTSD cases and controls is not observed in females.
Table 2
Two-way ANCOVA Table for RPC monocyte estimates (n= 469).




F p partial η2
Sex 0.336 1 0.336 1.469 0.226 0.003
PTSDlife 2.379 1 2.379 10.407 0.001*-
**
0.022
Age 2.309 1 2.309 10.101 0.002*-
**
0.021
ancPC1 0.000 1 0.000 0.001 0.977 0.000
ancPC2 0.219 1 0.219 0.957 0.329 0.002
Smoking 0.060 1 0.060 0.261 0.610 0.001
Sex:PTSDlife 1.146 1 1.146 5.011 0.026* 0.011
Residuals 105.399 461 0.229
**p < 0.05, **p < 0.01, ***p < 0.005.
4. Discussion
Methylomic profiles derived from peripheral blood offer a wealth of
information and can be harnessed to detect two dynamic measures of
immune state: 1) differences in leukocyte composition (i.e., proportions
of peripheral immune cell subtypes); and 2) true alterations in
methylation involved in epigenetic regulation of immune processes.
They are particularly well-suited for investigating PTSD because DNAm
encodes individual response to trauma and may play a key role in
PTSD-associated immune dysregulation. Given the prominent sex dif-
ferences in both PTSD prevalence (Kessler et al., 1995; Kilpatrick, 2013;
Kessler and Wang, 2008; Breslau, 1998; Breslau et al., 1997; Tolin and
Foa, 2006) and immune response (Klein and Flanagan, 2016; Osborne
et al., 2018), the primary goal of the present study was to investigate
whether PTSD is associated with sex-specific differences in leukocyte
composition, detectable by DNAm-based estimates. We found that
males with lifetime PTSD showed significantly higher monocyte pro-
portions than trauma-exposed males without PTSD; this difference was
not observed in females. No difference in monocyte proportions was
observed between current and remitted PTSD cases in males, suggesting
that this sex-specific difference may reflect a long-standing trait of
lifetime history of PTSD diagnosis, rather than current state of PTSD.
These findings were observed in both the primary RPC and comparison
CP-based sets of cell estimates, which were derived using non-con-
strained vs. constrained projection deconvolution algorithms, respec-
tively. Overall, our main finding of elevated monocyte proportions in
males, but not females with lifetime history of PTSD provides evidence
for a sex-specific difference in peripheral blood leukocyte composition
that may reflect long-standing changes associated with PTSD diagnosis
and is detectable in methylomic profiles, consistently across different
deconvolution algorithms.
Fig. 5. Lifetime PTSD by sex interaction plot for estimated marginal means (EMMs) of RPC monocyte estimates. Interaction plot shows a significant EMM difference
between lifetime PTSD cases (red) and controls (blue) in males, where mean monocyte estimates are higher in cases than controls. No significant EMM difference was
observed between PTSD cases and controls in females. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of
this article.)
Table 3
Summary for RPC monocyte estimates by group.
Sex PTSD n mean SE EMM SEEMM lower.CL upper.CL
Female no 135 7.113 0.2443 6.758 0.2214 6.330 7.200
Female yes 184 7.182 0.1691 7.014 0.1893 6.647 7.391
Male no 70 6.803 0.3228 6.507 0.2926 5.945 7.095
Male yes 80 8.103 0.3147 7.921 0.3063 7.331 8.535
This table describes untransformed RPC monocyte estimates by group (i.e., sex
and lifetime PTSD); n= count per group; EMM=estimated marginal means
(i.e., least squares means); SE= standard errors for regular means;
SEEMM= standard errors for EMM.
Lower and upper confidence limits (CL) are for 95% level. EMM and intervals
were back-transformed from the square root scale to the original scale of cell
subtype proportions (%). Significance level of alpha= 0.05 was used for EMM
comparisons. Results for pairwise comparison were averaged over levels for
current smoking. Degree of freedom was 461 and male lifetime PTSD cases were
significantly different from other groups.
In our study, we leveraged recent advances in reference-based de-
convolution methods (Teschendorff et al., 2017; Koestler, 2016; Salas,
2018) – specifically the EpiDISH algorithm (Teschendorff et al., 2017),
which (i) employs DNase hypersensitive site (DHS) data of leukocyte
subtypes to inform probe selection for their reference database and (ii)
introduces RPC, a non-constrained projection approach for reference-
based deconvolution. A comparative validation study on in-silico mix-
tures of purified cell DNAm profiles previously showed this newer RPC
approach to consistently perform better than the widely used CP ap-
proach (Houseman, 2012), based on root mean square error (RMSE)
and R2, at low noise levels (Teschendorff et al., 2017) typically en-
countered in real data (Teschendorff et al., 2017; Salas, 2018). Relevant
to our results, the study showed the difference in RMSE and R2 to be the
most prominent in CD8T cells (Teschendorff et al., 2017). This is con-
sistent with our comparison between RPC and CP estimates, which
showed CD8T cells to exhibit poorer correlation between RPC and CP
estimates relative to other leukocyte subtypes and the largest difference
in RPC-CP correlation between sexes. Similarly, the validation study
reported better performance of RPC, compared to CP, in monocytes,
with higher RMSE and lower R2 in CP compared to RPC, suggesting
RPC-based estimates were more robustly associated with true weights.
In light of the validation study, this suggests that our RPC-based esti-
mates were better able to resolve male-specific association of monocyte
proportions with lifetime PTSD. In all, our results were consistent with
the previously published validation study (Teschendorff et al., 2017)
and favored use of RPC estimates for modeling leukocyte composition.
However, as these methods have been developed recently, further va-
lidation and comparative studies are warranted.
Comparison of leukocyte subtype estimates by sex revealed sig-
nificant baseline sex differences in the distributions of NK cell and
CD8T cell proportions, with males showing greater median NK and
lower median CD8T cell proportions, using both RPC and CP based
estimates. This finding is consistent with a previous study that reported
sex differences in both leukocyte subtypes using estimates based on
minfi’s implementation of the Houseman approach (Inoshita, 2015) and
with immunology literature that reported higher NK cell counts and
proportions in males compared to females (Abdullah, 2012). A recent
study that modeled cell-specific methylation profiles also reported ro-
bust sex differences in CD56+ NK methylation patterns (White, 2017),
suggesting that this leukocyte subtype may be regulated by DNAm in a
sex-specific manner. Additionally, DNAm dynamics have been found to
drive effector functions in CD8T cells after stimulation (Scharer et al.,
2013; Suarez-Alvarez et al., 2012). Development of reference databases
that resolve the six main leukocyte subtypes to consider proportions of
subsets with shared lineage but different functionality/phenotype (e.g.,
naïve vs. memory vs. regulatory subtypes) may allow us to explore this
hypothesis and would greatly enrich our understanding of immune
activity.
Our main finding of higher monocyte proportions in male lifetime
PTSD cases is consistent with a previous study of Gulf War Illness (GWI)
in a predominantly male veteran cohort, which reported an association
between GWI and increase in monocyte count (Johnson et al., 2016).
However, comparable studies reporting monocyte counts from differ-
ential leukocyte count are generally lacking; the majority of immune
studies of PTSD have focused on inflammatory markers (e.g., cytokine
levels) and cellular activity, including spontaneous and stimulated cy-
tokine production, and studies of cell counts/proportions have focused
on lymphocytes, particularly T-cell subsets (Passos, 2015; Wang and
Young, 2016; Speer et al., 2018; Pace and Heim, 2011; Ironson et al.,
2007; Wong, 2002). Two PTSD studies that reported monocyte counts
based on white blood cell differential count found no significant dif-
ference in monocyte proportions (Rohleder et al., 2004; Gola, 2013),
which is consistent with our results in both sexes, but did not conduct
sex-stratified analyses. Additionally, a small study in adult females that
matched PTSD participants and controls for phase of menstrual cycle
agreed with our female-specific results and reported no difference be-
tween PTSD subjects and controls in percentage of any lymphocyte
subsets or total numbers of leukocytes, neutrophils, lymphocytes, or
monocytes (Altemus et al., 2006). PTSD studies investigating peripheral
lymphocyte numbers have reported mixed findings (Kawamura et al.,
2001; Zhou, 2014; Pace and Heim, 2011; Ironson et al., 2007; Rohleder
et al., 2004; Boscarino and Chang, 1999; de Kloet, 2007; Vidovic, 2011;
Vidovic, 2007; Jergovic, 2014), but more recent studies that further
resolved T-cell subpopulations support PTSD-associated differences in
T-cell composition indicative of pro-inflammatory skew (Sommershof,
2009; Zhou, 2014; Jergovic, 2014) and immunological aging (Aiello,
2016). Many of these studies were conducted predominantly in one sex
(often in male veteran cohorts) (Zhou, 2014; Boscarino and Chang,
Fig. 6. Density plots for RPC monocyte estimates comparing those with current PTSD, remitted PTSD, and trauma-exposed controls, stratified by sex. Distinguishing
between current and remitted PTSD cases suggests that the significant peak difference in male PTSD cases may be associated with long-standing PTSD trait, rather
than current PTSD state. Corresponding post-hoc Dunn test revealed no significant difference between current and remitted PTSD cases and significant differences
between PTSD case groups and trauma-exposed controls. Again, no significant differences were observed in females.
gene expression (Neylan, 2011) of CD14+ monocytes isolated from per-
ipheral blood. Given the inherent sex differences in innate immune response
(Klein and Flanagan, 2016; Nunn et al., 2009), as understood in the context
of infection, injury, and treatment of inflammatory disorders, sexually di-
morphic dynamics and effects may also exist in the context of neuroimmune
response to stress/trauma exposure (Bekhbat and Neigh, 2018). One re-
levant sex difference in monocytes involves the expression of IL-6, which
was suggested to be important for stress-induced anxiety-like behavior and
social avoidance in the RSD model (Niraula et al., 2019). Independent of
reproductive hormones (i.e., estradiol, dehydroepiandrosterone [DHEA],
progesterone), women were shown to have greater monocyte expression of
IL-6 across a circadian period than men, and sympathovagal balance was
negatively associated with monocyte IL-6 expression only in women
(O'Connor et al., 2007). On the other hand, a study examining sex differ-
ences in regulation of inflammatory cell recruitment and cytokine synthesis
found that ovarian hormones regulate phenotype, function, and numbers of
macrophages, but not T lymphocytes, in females (Scotland et al., 2011).
This fundamental sex difference may underlie more efficient recognition
and elimination of infectious stimuli without recruitment of circulating
neutrophils or excessive cytokine production in females, compared to males
(Scotland et al., 2011), and may also have implications in the context of
psychosocial stress exposure. Relatedly, statins, which have anti-in-
flammatory activity, modulate monocyte migration in a sex-specific
manner, such that both spontaneous and lipopolysaccharide-induced mi-
gration of isolated monocytes were found to be inhibited by statins in
women, but not men (Ruggieri, 2014).
Our observation of male-specific increase in monocyte proportions as-
sociated with lifetime PTSD may reflect fundamental sex differences in
leukocyte trafficking, tissue distribution, and thus composition in blood,
with implications for stress/trauma-induced neuroimmune alterations and
behavior. Of note, while the effect size detected in males translates to an
absolute difference of only 1.3% in monocyte proportions between parti-
cipants with vs. without PTSD (∼8.1% vs. 6.8%; Table 3), it also corre-
sponds to an increase of approximately 19% in overall monocytes among
men with lifetime PTSD. Furthermore, the lack of difference between re-
mitted and current PTSD observed in males may have a number of im-
plications for PTSD pathophysiology, including adverse health con-
sequences associated with PTSD across the life course in men, which may be
distinct from PTSD-associated health trajectories in women (Dedert et al.,
2010; Mitchell, 2013; McLean et al., 2011).
Although the current dataset combined two cohorts and known
pregnancies were excluded from our study, sample size and unavailable
phenotype data on pregnancy, timing of the menstrual cycle, hormonal
birth control use, well-harmonized measures of depression, and health
status, as well as gender-related variables, such as coping mechanisms,
are all limitations of this study. Future studies that account for hormone
levels and other fundamental physiological sex differences may help
identify female-specific associations between PTSD and leukocyte
composition and clarify if hormone-dependent processes influence
leukocyte composition dynamics. Additionally, both cohorts included
in this study are civilian, urban, and predominantly African-American,
so generalizability of our findings may be limited to this population.
Overall, our study implements current state-of-the-art methods to illus-
trate feasibility of using DNAm-based leukocyte composition estimates to
probe immune profiles. Our literature-supported finding of higher DNAm-
based monocyte proportions in males may be an informative metric to in-
clude as part of a diagnostic biomarker panel for PTSD in males, and future
study in females, with consideration for hormonal status, may elucidate a
female-specific panel as well. Differential methylation markers discovered
in sex-stratified EWAS, which account for these cell estimates as covariates,
are other prime candidates to be included in such sex-specific biomarker
panels. Furthermore, in addition to being able to infer leukocyte composi-
tion when complete blood count data is not available, these DNAm-based
estimates of leukocyte composition can be used to determine cell-specific
differential methylation profiles. In fact, methods and validation for cell-
specific differential methylation analyses have been published very recently
1999; de Kloet, 2007; Vidovic, 2011, 2007; Jergovic, 2014) and those 
based on both sexes did not conduct sex-stratified a nalyses (Aiello, 
2016; Sommershof, 2009; Rohleder et al., 2004). To our knowledge, no 
authoritative study of sex differences in complete blood counts in PTSD 
has yet been published, and studies of sex differences i n PTSD have 
generally been lacking, with a number of large-scale studies conducted 
in predominantly male military cohorts (or on female-only cohorts, e.g. 
Nurses’ Health Study II) (Koenen, 2009; Sumner, 2017).
While not for PTSD, a study of depression that examined white blood 
cell differential count noted a significant increase in monocyte count and 
proportions among males with major depressive disorder (MDD), but not 
females, and a significant s ex b y d iagnosis i nteraction ( Maes, 1992). 
Likewise, a separate longitudinal study following MDD inpatients also 
reported elevated monocyte counts in patients compared to controls, and 
this was driven by men (Seidel, 1996). Additionally, a decrease in de-
pression severity was associated with a decrease in monocyte counts 
(Seidel, 1996), suggesting that monocytes may be related to clinical 
improvement. Similarly, the presence and severity of atherosclerosis, 
another condition linked to PTSD via systemic low-grade inflammatory 
state (Brouwers et al., 2015), are also associated with an increase in 
monocyte count in males, but not females (Huang, 2001).
Further prospective investigation of PTSD is needed to determine 
whether the higher monocyte proportion observed in males reflects an 
increased susceptibility for developing PTSD or if it reflects a n im-
munological shift in response to the precipitating trauma associated with 
PTSD psychopathology. However, studies in a male rodent model pro-
vide strong evidence for the latter and have been important for estab-
lishing the relationship between peripheral immune cells and the brain in 
the context of psychosocial stress and associated behavior. Repeated 
social defeat (RSD) was found to induce myelopoiesis and release in-
flammatory ( Ly6Chi) m onocytes i nto c irculation v ia s ympathetic sig-
naling, and this increased level of circulating peripheral monocytes was 
associated with recruitment of pro-inflammatory monocytes/macro-
phages to the brain and neuroinflammation (Wohleb, 2011; Engler et al., 
2004; Weber et al., 2017). Increased proportion of these peripheral 
monocytes and macrophage recruitment to the brain were also demon-
strated to correspond with development, maintenance, and re-establish-
ment of RSD-induced anxiety-like behavior; blockade of this recruitment 
(via splenectomy or β-adrenergic receptor blockage) before RSD was 
found to prevent development of anxiety-like behavior (Wohleb, 2014; 
McKim, 2016). Additionally, a recent paper discerned that stress-induced 
anxiety-like behavior and social avoidance are dependent on an increase 
in IL-6 after stress exposure, which induces a primed transcriptional 
profile in monocytes recruited to the brain and propagates IL-1β medi-
ated inflammation associated with anxiety-like behavior (Niraula et al., 
2019). These studies implicate peripheral monocytes in directly affecting 
relevant PTSD-like behavior after stress exposure in males (Bierhaus, 
2003; Grisanti, 2010). Very recently, the first s tudy u sing a  modified 
version of the RSD paradigm was conducted in female mice and reported 
a similar onset of anxiety-like and social avoidance behavior, increase in 
myelopoiesis, increase in peripheral monocyte proportions, and recruit-
ment of peripheral myeloid cells to the brain, 14 h after the last RSD 
cycle (Yin, 2019). Continued work based on this paradigm at multiple 
time points may be fruitful for investigating if there are sex differences in 
the kinetics of leukocyte trafficking and ti ssue di stribution, especially 
since recent investigations in other PTSD-relevant rodent models suggest 
fundamental sex differences in neurobiological response to t rauma ex-
posure (Pooley, 2018) and in regulation of stress/trauma-induced neu-
roinflammatory p riming/neuroimmune a lterations ( Fonken, 2018; 
Bekhbat and Neigh, 2018). Furthermore, a social stress paradigm in 
pregnant rats reported lower numbers of monocytes in stressed females 
than control female rats (Stefanski et al., 2005), illustrating the im-
portance of considering different paradigms and breeds/species.
Although no studies of PTSD have investigated sex differences in 
monocyte counts or methylomic profiles, chronic PTSD-associated sex dif-
ferences were noted in transcriptional regulation (O'Donovan, 2011) and
5. Conclusion
By combining DNA methylation datasets from two civilian cohorts,
the current study found significantly higher monocyte proportions in
males with lifetime PTSD compared to trauma-exposed controls, a dif-
ference that was not observed in females. This sex-specific difference in
peripheral blood leukocyte composition may reflect a long-standing
trait of PTSD diagnosis, rather than current state of PTSD. While this
finding was confirmed using two different cell estimation approaches
(i.e., deconvolution algorithms), the recently developed non-con-
strained projection approach (RPC) appears better suited for modeling
leukocyte composition. Methylome-based characterization of immune
profiles holds special promise for the study of PTSD and continued
development of reference databases and validation of methods will
build on these recent improvements to enrich our understanding of sex-
specific immune dysregulation associated with PTSD.
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